+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Breast Cancer Market and Competitive Landscape - 2020

  • ID: 5023425
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Breast Cancer Market and Competitive Landscape - 2020, provides comprehensive insights into the Breast Cancer pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Breast Cancer market size and drug sales. It also provides insights into Breast Cancer epidemiology and late stage pipeline.

This research covers the following: Breast Cancer treatment options, Breast Cancer late stage clinical trials pipeline, Breast Cancer prevalence by countries, Breast Cancer market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Breast Cancer pipeline: Find out drugs in clinical trials for the treatment of Breast Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Breast Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Breast Cancer by countries
  • Breast Cancer drugs: Identify key drugs marketed and prescribed for Breast Cancer in the US, including trade name, molecule name, and company
  • Breast Cancer drugs sales: Find out the sales value for Breast Cancer drugs by countries
  • Breast Cancer market valuations: Find out the market size for Breast Cancer drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Breast Cancer drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Breast Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Breast Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze Breast Cancer drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Breast Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Breast Cancer Treatment Options

2. Breast Cancer Pipeline Insights
2.1. Breast Cancer Phase 3 Clinical Trials
2.2. Breast Cancer Phase 2 Clinical Trials
2.3. Breast Cancer Phase 1 Clinical Trials

3. Breast Cancer Epidemiology Analysis by Countries

4. Germany Breast Cancer Market Insights
4.1. Marketed Drugs for Breast Cancer in Germany
4.2. Germany Breast Cancer Market Size & Forecast
4.3. Germany Breast Cancer Drugs Sales Forecast
4.4. Germany Breast Cancer Market Share Analysis

5. France Breast Cancer Market Insights
5.1. Marketed Drugs for Breast Cancer in France
5.2. France Breast Cancer Market Size & Forecast
5.3. France Breast Cancer Product Sales Forecast
5.4. France Breast Cancer Market Share Analysis

6. Italy Breast Cancer Market Insights
6.1. Marketed Drugs for Breast Cancer in Italy
6.2. Italy Breast Cancer Market Size & Forecast
6.3. Italy Breast Cancer Product Sales Forecast
6.4. Italy Breast Cancer Market Share Analysis

7. Spain Breast Cancer Market Insights
7.1. Marketed Drugs for Breast Cancer in Spain
7.2. Spain Breast Cancer Market Size & Forecast
7.3. Spain Breast Cancer Product Sales Forecast
7.4. Spain Breast Cancer Market Share Analysis

8. UK Breast Cancer Market Insights
8.1. Marketed Drugs for Breast Cancer in UK
8.2. UK Breast Cancer Market Size & Forecast
8.3. UK Breast Cancer Product Sales Forecast
8.4. UK Breast Cancer Market Share Analysis

9. Europe Breast Cancer Market Insights
9.1. Europe Breast Cancer Market Size & Forecast
9.2. Europe Breast Cancer Product Sales Forecast
9.3. Europe Breast Cancer Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Breast Cancer Phase 3 Clinical Trials, Global, 2020
Table 2: Breast Cancer Phase 2 Clinical Trials, Global, 2020
Table 3: Breast Cancer Phase 1 Clinical Trials, Global, 2020
Table 4: Breast Cancer Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Breast Cancer in Germany, 2019
Table 6: Germany Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Breast Cancer Product Sales ($mn), 2016 - 2024
Table 8: Germany Breast Cancer Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Breast Cancer in France, 2019
Table 10: France Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Breast Cancer Product Sales ($mn), 2016 - 2024
Table 12: France Breast Cancer Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Breast Cancer in Italy, 2019
Table 14: Italy Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Breast Cancer Product Sales ($mn), 2016 - 2024
Table 16: Italy Breast Cancer Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Breast Cancer in Spain, 2019
Table 18: Spain Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Breast Cancer Product Sales ($mn), 2016 - 2024
Table 20: Spain Breast Cancer Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Breast Cancer in UK, 2019
Table 22: UK Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Breast Cancer Product Sales ($mn), 2016 - 2024
Table 24: UK Breast Cancer Market Events and Trends, 2016 - 2024
Table 25: Europe Breast Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Breast Cancer Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Breast Cancer Pipeline by Phase (%), Global, 2020
Figure 2: Breast Cancer Prevalence by Countries, 2016 - 2024
Figure 3: Germany Breast Cancer Market Size ($mn), 2016 - 2024
Figure 4: Germany Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 5: Germany Breast Cancer Market Share by Drugs (%), 2019
Figure 6: Germany Breast Cancer Market - Future Market Share (%), 2024
Figure 7: France Breast Cancer Market Size ($mn), 2016 - 2024
Figure 8: France Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 9: France Breast Cancer Market Share by Drugs (%), 2019
Figure 10: France Breast Cancer Market - Future Market Share (%), 2024
Figure 11: Italy Breast Cancer Market Size ($mn), 2016 - 2024
Figure 12: Italy Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 13: Italy Breast Cancer Market Share by Drugs (%), 2019
Figure 14: Italy Breast Cancer Market - Future Market Share (%), 2024
Figure 15: Spain Breast Cancer Market Size ($mn), 2016 - 2024
Figure 16: Spain Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 17: Spain Breast Cancer Market Share by Drugs (%), 2019
Figure 18: Spain Breast Cancer Market - Future Market Share (%), 2024
Figure 19: UK Breast Cancer Market Size ($mn), 2016 - 2024
Figure 20: UK Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 21: UK Breast Cancer Market Share by Drugs (%), 2019
Figure 22: UK Breast Cancer Market - Future Market Share (%), 2024
Figure 23: Europe Breast Cancer Market Size ($mn), 2016 - 2024
Figure 24: Europe Breast Cancer Product Sales ($mn), 2016 - 2024
Figure 25: Europe Breast Cancer Market Share by Drugs (%), 2019
Figure 26: Europe Breast Cancer Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll